PRESS RELEASE
News
-
-
PRESS RELEASE
Protagonist Announces Positive Topline Results From Phase 3 ICONIC Studies of Icotrokinra (JNJ-2113), a First-in-Class Investigational Targeted Oral Peptide That Selectively Blocks the IL-23 Receptor in Plaque Psoriasis
Protagonist announces positive Phase 3 ICONIC study results of icotrokinra, a first-in-class oral peptide for plaque psoriasis, achieving key endpoints and milestone payments under Johnson & Johnson collaboration -
-
-
PRESS RELEASE
Further postponement of the publication of the 2023 annual financial statements
LIBERO football finance AG announces further postponement of the 2023 annual financial statements publication to mid-January 2025 due to delays in finalizing agreements related to acquiring shares in Bridgeburg Invest S.L. and resolving legal disputes with FC Barcelona -
REGULATED PRESS RELEASE
Louis Hachette Group confirms its dividend policy ahead of listing on Euronext Growth (Paris)
Louis Hachette Group confirms its dividend policy ahead of listing on Euronext Growth (Paris) in 2025. The company aims to distribute a minimum of 85% of received dividend as part of its value creation strategy -
PRESS RELEASE
8th 'Gratitude: Nanking Safety Zone' Int’l Peace Hiking Kicks Off in E.China Nanjing City
The 8th Annual 'Gratitude: Nanking Safety Zone' International Peace Hiking Ceremony in Nanjing honored foreign individuals for sheltering Chinese refugees. Participants visited historical sites to commemorate the humanitarian efforts -
-
-
